P020. Defining molecular signatures to personalise management of patients with early breast cancer
| dc.contributor.author | Allen, N | en_US |
| dc.contributor.author | Allen, M | en_US |
| dc.contributor.author | Gomm, J | en_US |
| dc.contributor.author | Nelan, R | en_US |
| dc.contributor.author | Nagano, A | en_US |
| dc.contributor.author | Chelala, C | en_US |
| dc.contributor.author | Jones, L | en_US |
| dc.date.accessioned | 2022-02-09T14:25:16Z | |
| dc.date.issued | 2021-05 | en_US |
| dc.identifier.issn | 0748-7983 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/76712 | |
| dc.format.extent | e301 - ? | en_US |
| dc.publisher | Elsevier | en_US |
| dc.title | P020. Defining molecular signatures to personalise management of patients with early breast cancer | en_US |
| dc.type | Conference Proceeding | |
| dc.identifier.doi | 10.1016/j.ejso.2021.03.024 | en_US |
| pubs.issue | 5 | en_US |
| pubs.notes | Not known | en_US |
| pubs.volume | 47 | en_US |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
